SCHEMBL24724813

SCHEMBL24724813

CCC(C)C(NC)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.46
▸ CPB2 Q96IY4 2/20 0.42
▸ BACE1 P56817 2/20 0.41
▸ NTSR2 O95665 1/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ GRIN3A Q8TCU5 1/20 0.39
▸ CCNA2 P20248 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CCNA1 P78396 2/20 0.38
▸ CTSD P07339 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24724812 0.87 BACE1 (0.47) FOLH1BACE1NTSR2NTSR1GRIN2D
SCHEMBL24725396 0.85 BACE1 (0.47) FOLH1BACE1NTSR2NTSR1GRIN2D
SCHEMBL24725397 0.85 BACE1 (0.52) BACE1NTSR2NTSR1GRIN2DGRIN3B
SCHEMBL31663474 0.83 BACE1 (0.51) BACE1NTSR2NTSR1CCNA2CDK2
SCHEMBL31753464 0.82 FOLH1 (0.53) FOLH1CPB2
SCHEMBL30996905 0.82 BACE1 (0.54) BACE1NTSR2NTSR1CCNA2CDK2
SCHEMBL31554824 0.81 GRIN2D (0.48) BACE1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29631655 0.81 FPR1 (0.50) FOLH1CPB2BACE1CTSD
SCHEMBL30890810 0.81 FOLH1 (0.52) FOLH1CPB2BACE1NTSR2NTSR1
SCHEMBL30400254 0.81 FOLH1 (0.54) FOLH1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback